The Lancet Digital Health in conversation with

Predicting the added benefit of adjuvant chemotherapy

February 19, 2020 The Lancet
Predicting the added benefit of adjuvant chemotherapy
The Lancet Digital Health in conversation with
More Info
The Lancet Digital Health in conversation with
Predicting the added benefit of adjuvant chemotherapy
Feb 19, 2020
The Lancet

Prof Anant Madabhushi and Dr Samuel talk about the utility of a radiomic risk score applied to CT scans of patients with early stage non-small cell lung carcinoma.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Show Notes

Prof Anant Madabhushi and Dr Samuel talk about the utility of a radiomic risk score applied to CT scans of patients with early stage non-small cell lung carcinoma.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv